Le Lézard
Classified in: Covid-19 virus
Subject: Conference

Retractable Technologies, Inc. Reports Change to Meeting Date


Retractable Technologies, Inc. (NYSE American: RVP) (the "Company") today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the date of the 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the "Annual Meeting") has been changed to June 22, 2020 at 10:00 a.m. The adjourned meeting is expected to be held at Little Elm Town Hall located at 100 West Eldorado Parkway, Little Elm, Texas 75068. However, the Company has also secured a vendor to assist in facilitating a virtual meeting on June 22, 2020 if an in-person meeting is still not advisable due to COVID-19 concerns. If the format of the meeting is changed to a virtual meeting, a notice will be distributed by press release.

A notice regarding the change to the date of the Annual Meeting (the "Notice") is being filed with the Securities and Exchange Commission together with this press release. Additional information regarding the Annual Meeting, shareholder participation and voting is provided in the Notice.

The Company manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. The Company's products are distributed by various specialty and general line distributors.

For more information on Retractable Technologies, Inc., visit its website at www.retractable.com.


These press releases may also interest you

at 10:12
Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:05
Gibson Dunn and Barrasso Usdin File Civil Rights Lawsuit to Secure Constitutional Rights of Young Woman Incarcerated for Over Six Months Despite Never Being Charged With a Crime
Gibson, Dunn & Crutcher LLP and Barrasso Usdin Kupperman Freeman & Sarver, LLC announce the filing of a civil rights action on behalf of Tayjha Alfred against Martin Bofill ("Bo") Duhé, the District Attorney for the 16th Judicial District of...

at 10:01
Control Valve Market worth $13.0 billion by 2029 - Exclusive Report by MarketsandMarketstm
The global Control Valve market is expected to grow from USD 10.0 billion in 2024 to USD 13.0 billion by 2029, registering a CAGR of 5.4% according to a new report by MarketsandMarketstm. The global market for control valves has experienced...

at 10:00
PER PERSON HEALTH CARE SPENDING EXCEEDED $6,700 IN 2022
A new report from the Health Care Cost Institute (HCCI) shows that, even with fluctuations in 2020 and 2021, per person health care spending grew from 2018 to 2022. Over the five years, average prices increased by 14% and utilization went up by about...

at 10:00
2024 ASCO | Mabwell to Present Clinical Data of 9MW2821 in Multiple Advanced Solid Tumor
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 for multiple advanced solid tumors will be presented...

at 09:49
Adyton to recommence work activities on Feni Island Gold/Copper Project
Adyton Resources Corporation is pleased to report that on closing the recently announced C$1.5M financing, work activities on its 100% owned Feni Island Gold-Copper Project have commenced in earnest with the engagement of globally renowned...

More news about Covid-19 virus...


News published on and distributed by: